Multidisciplinary Association For Psychedelic Studies

FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays

Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?

FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care

Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?

FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care

Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy

Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD

Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy

Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD

How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare

MDMA Therapy For PTSD Closer To Legality As Key FDA Approval Meeting Approaches, Sparking Hope And Controversy

Multidisciplinary Association For Psychedelic Studies Recent News

Meet Oregon's Legal Psilocybin Retreats Powered By NASA And Ivy League Talent

Discover Odyssey's pioneering psilocybin retreats in Oregon, founded by NASA, Stanford, Harvard brains for novel mental health therapy.

NFL's Jon Feliciano Takes His Psychedelics Advocacy To The Field: Chooses MAPS As His "My Cleats, My Cause"

The latest San Francisco 49ers and Philadelphia Eagles match (42-19) brought on additional highlights on players’ charity choice for the NFL “My Cleats, My Cause” campaign. This week's NFL game between the San Francisco 49ers and the Philadelphia Eagles brought additional excitement to the field thanks to 49ers&r

Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News

The long-awaited psychedelic-assisted treatment alternative for Post-Traumatic Stress Disorder (PTSD) is moving closer to federal approval.

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

World's Largest Psychedelics Conference Boasts 12K Attendees

Burning Man CEO Learned 'So Much' About Psychedelics In BRC: 'We're Here For The Love'

Burning Man CEO Marian Goddell attended Psychedelic Science 2023 in Denver, where she spoke with MAPS strategic initiatives officer Lia

World's Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees

The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week, which gathered over 12,000 people from the entire psy

Psychedelic Science 101: Dr. Huberman Calls On Academics To Have 'The Guts To Take On Something Risky'

This year’s psychedelics gathering in Denver, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), brought together some of the most knowledgeable folks in the fields of science, business, and p

Gov. Polis To Open MAPS' Psychedelic Science 2023 Event Where 2 New Shulgin Compounds Will Be Revealed

Psychedelic Science, this year’s gathering hosted by the legendary nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by Momentum Events, announced its final agenda, which will include opening remarks by Colorado Governor Jared Polis, featured speakers and a new local day-pass option.

The Flaming Lips, Eric Andre, Reggie Watts And Many More At MAPS 2023 Psychedelic Event

MAPS’ Psychedelic Science 2023 is taking place this June in Denver.

MDMA Therapy For PTSD Nearing Legalization In US And Worldwide, MAPS Releases Promising Data

Zinger Keypoints: Long-term (over 1 year) follow-up reflects lasting improvements in symptom severity. Data confirms prior Phase 2 studies on MDMA-assisted therapy’s sustained effect on PTSD treatment.

Psychedelic Science 2023: Details On Agenda And Acclaimed Speakers At MAPS Annual Gathering

The historical non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) has announced the agenda and featured speakers of its Psychedelic Science 2023 conference taking place June 19-25, 2023 in Denver, Colorado, organized by Momentum Events.

Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers

In its capacity as a financial news and media outlet, Benzinga has added six new members to its Psychedelics Advisory Council.

Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund

Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million fund.

MAPS Gets A New Partner To Study MDMA Therapy In Patients With PTSD

In recent months, the psychedelics space has been ground for increasing collaborations. In some cases it was to advance scientific studies.

Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say

Patents are the golden eggs of the booming psychedelic space.

Ecstasy Research Trial Completes Enrollment, Moves Closer To Approval To Treat PTSD

The non-profit Multidisciplinary Association for Psychedelics Studies (MAPS) and its subsidiary MAPS Public Benefit Corporation finished the enrollment stage for the second Phase 3 clinical trial on MDMA (MAPP2).

DEA Under Fire For Blocking Psilocybin As Treatment For Terminally Ill Cancer Patients

The Drug Enforcement Administration (DEA) will face activists at its headquarters in Arlington, Virginia, reported Mary-Elizabeth Gifford and Justin Grant of Lucid News. Protestors intend to block the entrance to the building to call attention to the rights

Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS

Psychedelic Companies Keenly Aware Of Creating Therapies As Healthcare Reimbursement Possibility Looms

In the quest to design effective and affordable psychedelic treatments for a range of maladies that include PTSD and depression, one key thought on the minds of company executives and clinicians alike seems to be how to motivate healthcare insurance companies to cover the cost of psychedelic therapies.

Australian Psychiatrist Sues State Of Victoria For Denying MDMA Treatment For Ailing Patient

The Australian state of Victoria faces a seminal lawsuit that seeks to make MDMA available for severe mental illness.

Can MDMA Treat Traumatic Brain Injury? $1.5 Million Are Being Committed To Finding Out

Wesana Health (CSE: WESA) (OTCQB: WSNAF) and the Multidisciplinary Association for Psychedelic Studies (MAPS) are teaming up to analyze the effectiveness of MDMA-assisted therapy in the treatment of traumatic brain injury (TBI).

Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In just a couple of years, psychedelics took the world of investing by storm.